PHARMA STOCKS TO BUY TODAY
Divi’s Laboratories shares gain another 5% after Q2 results. Here’s why Jefferies raised target price by 23%
Shares of Divi’s Laboratories jumped 5% following a 64% YoY surge in Q2 FY27 net profit to Rs 1,127 crore. Brokerage Jefferies raised its target price by 23% to Rs 12,550, citing robust CDMO business expansion, strong EBITDA margins, and a solid GLP peptide pipeline.
Divi's Labs shares jump 8% to fresh 52-week high after Q2 profit soars 64% YoY. What brokerages say after bumper results?
Divi’s Laboratories shares surged over 8% during Muhurat Trading, hitting a 52-week high after Q2 FY27 net profit jumped 64% to ₹1,127 crore. Revenue grew 35%, while brokerages differed on valuation concerns and future growth prospects.
Ahead of Market: 10 things that will decide stock market action on Monday
Sensex and Nifty ended lower during Muhurat Trading on November 8, snapping a six-session winning streak. Nifty slipped below 25,000 as investors booked profits. However, broader market sentiment remained positive, with 2,716 NSE stocks advancing against 736 declines.
Muhurat Trading 2026: Sensex falls 29 points, Nifty below 25,000 as market snaps 6-day explosive rally on Diwali. What lies ahead in Samvat 2083?
The Indian stock market experienced sharp gains during the Muhurat Trading session on Diwali. Sensex increased by 350 points, surpassing 81,380, indicating strong investor interest. Nifty 50 rose over 80 points, crossing 23,100 as well. Tata Steel, Sun Pharma, BEL, and HDFC Bank contributed to these gains, while some stocks faced losses. Overall, the market breadth remained positive, with more advances than declines.
Muhurat Trading 2026: Which stocks to buy during special session today? Analysts list top technical picks
Investors are preparing for the Muhurat Trading session today, which marks the beginning of Samvat 2083. Stock exchanges BSE and NSE will hold the session for an hour starting at 2.20 pm. Analysts from HDFC Securities and Axis Securities have identified several stocks as top picks for this trading period. Stocks like HCL Technologies and IIFL Finance have been highlighted for their potential upside.
- Go To Page 1
US stocks today: Nasdaq rebounds as chip stocks recover from steep losses, rate fears persist
US stocks rebound as chipmakers recover from Thursday's steep AI-led selloff, lifting the Nasdaq 1.73%. Nvidia, AMD, Intel and Micron lead the recovery, while stronger-than-expected October jobs data revive concerns over a December Fed rate hike. Airbnb rallies after raising its full-year revenue growth forecast, while Atlassian shares decline.
US stock market today: Why is the Nasdaq up 1% while the Dow Jones falls? S&P 500 turns green amid tech stock volatility and Fed rate hike fears over strong October jobs report
US stock market today: Wall Street is seeing a split recovery on Friday after Thursday's AI-led sell-off. The Nasdaq has jumped 1.02%, while the Dow Jones has fallen 0.90% and the S&P 500 gained 0.29%. Nvidia, AMD, Intel, Broadcom and Micron were among the chipmakers recording gains in early trading. Nvidia's rebound has been particularly important because of its large weight in the broader market.
Stock Radar: Karur Vysya Bank stock retreats from October highs; took support above 50-DMA; time to buy?
Karur Vysya Bank stock rebounded after testing its 50-DMA and broke out of a multi-month ascending triangle pattern. Supported by strong trading volumes and bullish EMA alignment, analysts recommend buying the stock with a positional target of Rs 460 and a weekly closing stop-loss set at Rs 280.
These large-, mid- and small-cap stocks have upside potential of up to 31% in 1 year, according to analysts
In the last two years, the world has learnt that you can never quite predict what US President Trump will do next. Tomorrow, to pull attention one way or another, there could well be some more action against Iran, changing the mood again in a single afternoon. So, the improvement in sentiment is real, but it is also fragile.
Wall Street fear gauge soars and retail traders bolt as markets in tailspin
Retail investors experienced significant losses as they sold over $1 billion in stocks due to rising fears. The Cboe Volatility Index spiked sharply, indicating increased market anxiety among traders and investors. Major stock indexes declined, driven down by fears that a Democratic sweep could hinder AI spending. Options market activity reflected heightened demand for hedges, as retail investor sentiment shifted.
Stock markets down today: Dow Jones plunges 1,753 points, S&P 500 drops 4% and Nasdaq enters correction - why Wall Street reversed its post-election rally
Stock markets down today: Wall Street's post-election rally quickly turned into a major sell-off as the Dow plunged 1,753 points and the Nasdaq entered correction territory. Fears that Democratic victories could slow AI data-center expansion triggered heavy losses in Nvidia, AMD, Micron and other technology stocks, wiping out Wednesday's gains.
Ahead of Market: 10 things that will decide stock market action on Friday
Indian markets staged a powerful rally, with Sensex jumping 2,009 points and Nifty gaining 576 points. Improved global sentiment, easing crude prices, US midterm election results, foreign investor buying and strong Q2 earnings lifted market capitalisation above Rs 500 lakh crore.
Market wrap: Bajaj Finance, Shriram Finance, Apollo Hospital, ONGC top gainers and losers on Nifty and Sensex on Thursday
Indian equity markets staged a strong rally on Thursday, with the Sensex surging over 2,000 points and the Nifty jumping 576 points amid optimism following the US midterm election results. Bajaj Finance, Shriram Finance and M&M led the gainers, while Apollo Hospitals and ONGC featured among the top laggards.
Pills are paying off! Pharma stocks lead 2026 rally with up to 112% return
In 2026, India's pharmaceutical stocks are making headlines with impressive year-to-date gains. This surge is driven by strong domestic demand alongside enhanced profitability from new product launches. Notable players like Laurus Labs and Gland Pharma have recorded remarkable returns, topping 100%. Amid challenges faced by other sectors, the pharmaceutical field demonstrates resilience. Analysts are optimistic but advise exercising caution regarding potential market volatility and the durability of this sector's performance.
Stock split alert! Last day to buy this Ashish Kacholia-backed multibagger smallcap stock ahead of record date for 1:5 split
After the stock split takes effect, her 10 shares will be split into 500 shares worth Rs 20 each, keeping the total value of her stock holding the same at Rs 1,000.
Global Market Today: Asian stocks rise as oil slides after US midterm elections
Benchmark indexes rose in Japan and Australia, pushing the MSCI Asia Pacific Index up by 0.3%. That was after the S&P 500 Index jumped 1.6%, its biggest gain in three months, and the tech-heavy Nasdaq 100 climbed 0.9%. South Korea was the outlier, with the Kospi Index dropping 2.7%, reflecting investor concerns over the future of data-center development and losses in US chip stocks.
Stocks in news: BSE, Lenskart, Nykaa, Bharti Airtel, LIC, Aurobindo Pharma and Nalco
Indian equity markets have enjoyed a remarkable stretch, registering gains for five consecutive sessions. The Nifty 50 index showed impressive growth, sparking optimism for a breakout beyond 24,000. Companies like Lenskart, Aurobindo Pharma, and BSE are in the spotlight as they report positive earnings. Experts advise keeping an eye on the support levels as the bullish trend persists.
AI data center stocks dip, renewables surge after Democrat sweep in US midterm elections
The Democratic sweep, which included victories in traditional Republican strongholds and key data-center hubs Texas and Georgia, will usher in divided government in Washington and raises the prospect of greater congressional oversight of industries that benefited from Republican control.
AI data center stocks dip, renewables surge after Democrat sweep in US midterm elections
AI data centre stocks declined while renewable energy and healthcare shares rallied after Democrats won control of Congress in the US midterm elections. Investors assessed the possibility of tighter AI oversight and continued clean energy support. Defence contractors and prison operators fell amid concerns over changing government spending and immigration policies.
Ahead of Market: 10 things that will decide stock market action on Thursday
Indian markets extended their rally, with Sensex gaining 384 points to 77,301 and Nifty rising 150 points to 23,961, marking two-month highs. Positive sentiment, strong earnings, festive demand and buying across mid- and small-caps supported gains.
Market wrap: BEL, Adani Ent, TCS, HCL Tech top gainers and losers on Nifty and Sensex on Wednesday
Indian equity markets advanced for the fifth consecutive session as easing crude oil prices and US-Iran diplomatic hopes boosted sentiment. Nifty gained 150 points, while Sensex rose 383 points, led by realty, metal and consumer durables stocks.
Emcure Pharma shares hit 10% upper circuit after FY27 guidance hike; Jefferies raises target price by 8%
Emcure Pharma shares hit a 10% upper circuit after strong Q2 FY27 results prompted the company to raise its full-year growth guidance. Brokerages turned more positive, citing robust international business, improving domestic growth and a strong product pipeline.
HRV Pharma buys Germany's Phatebo
The acquisition marks virtual pharmaceutical company HRV's entry beyond active pharmaceutical ingredients (APIs) into finished formulations, giving it its first finished formulations business alongside a licenced operating entity in Germany.
Bonus issue alert! Choice International to reward shareholders with 1:1 bonus shares. Check details
Choice International has approved a 1:1 bonus issue, its first such corporate action in two years. Under the proposal, shareholders will receive one bonus share for every share held on the record date, which will be announced later. The move will double the number of outstanding shares without changing the company’s market capitalisation, while potentially improving stock liquidity and affordability.
Bonus issue alert! Last day to buy this Rakesh Jhunjhunwala-backed smallcap pharma stock for 1:1 bonus bonanza
As per Sebi's T+1 settlement cycle, investors must buy the company's shares at least one trading day before the record date for them to be credited to their demat accounts and qualify for the bonus issue. This makes today the last day to buy the stock to be eligible for the bonus shares.
Market wrap: RIL, Tata Steel, Infosys, ICICI Bank top gainers and losers on Nifty and Sensex on Monday
Indian markets rallied sharply, with Sensex gaining 1.66% to 75,693 and Nifty rising 1.68% to 23,441. Strong quarterly earnings lifted investor sentiment, led by Reliance Industries, metals and oil and gas stocks, while market breadth remained positive.
Ahead of Market: 10 things that will decide stock market action on Monday
Sensex and Nifty ended the week up about 0.5%, supported by resilient large-cap, IT and healthcare stocks. However, midcap and smallcap indices fell as much as 2% amid rising crude oil prices, inflation concerns and a global technology sell-off.
Ahead of Market: 10 things that will decide stock market action on Thursday
Indian markets closed lower on Wednesday as rising crude oil prices and Middle East tensions hurt sentiment. Sensex fell 353 points to 73,246, while Nifty slipped 51 points to 22,699 despite a late recovery.
Load More
